A Phase 1, Open-label, Multi-Center Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-017 Monotherapy in Patients with Advanced Solid Tumors and Hematological Malignancies.
- Voskoboynik, Mark (Primary Chief Investigator (PCI))
- Tran, Ben (Chief Investigator (CI))
- Gan, Hui K (Chief Investigator (CI))
- Hawkins, Cheryl-Ann (Project Manager)